Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building
Ultragenyx Pharmaceutical bought two precedence overview vouchers, every from an FDA approval of a gene remedy. Each therapies got here ...
Tag: pipeline
Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs
Kailera Therapeutics’ IPO proceeds will help world medical trials for its weight problems drug candidates. In the meantime, proteomics firm ...
Candid Therapeutics Strikes Up Merger With Rallybio to Advance Its Autoimmune Drug Pipeline
Together with the reverse merger, Candid Therapeutics introduced $505 million in non-public financing to help its pipeline of T cell ...
Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential
Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential purposes in a number of autoimmune issues. Relying ...
Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition
Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...
MuscleTech’s Quality Control Excellence and Innovation Pipeline with Raza Bashir
On Episode #183 of the PricePlow Podcast, Mike and Ben sit down with Raza Bashir, Chief Innovation Officer at MuscleTech ...
Sarepta Slashes Staff, Maps Path Forward for Gene Therapy and Narrower Pipeline
Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy ...
AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
Recursion cuts nearly half of its pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies
Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!